Literature DB >> 19018

Interconversion of myo- and scyllo-inositol with simultaneous formation of neo-inositol by an NADP+ dependent epimerase from bovine brain.

P P Hipps, W H Holland, W R Sherman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 19018     DOI： 10.1016/s0006-291x(77)80202-7

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN： 0006-291X            Impact factor:   3.575


× No keyword cloud information.
  7 in total

Review 1.  The "Other" Inositols and Their Phosphates: Synthesis, Biology, and Medicine (with Recent Advances in myo-Inositol Chemistry).

Authors:  Mark P Thomas; Stephen J Mills; Barry V L Potter
Journal:  Angew Chem Int Ed Engl       Date:  2015-12-22       Impact factor: 15.336

Review 2.  Supraphysiologic-dose anabolic-androgenic steroid use: A risk factor for dementia?

Authors:  Marc J Kaufman; Gen Kanayama; James I Hudson; Harrison G Pope
Journal:  Neurosci Biobehav Rev       Date:  2019-02-25       Impact factor: 8.989

Review 3.  A guide to the metabolic pathways and function of metabolites observed in human brain 1H magnetic resonance spectra.

Authors:  Caroline D Rae
Journal:  Neurochem Res       Date:  2013-11-21       Impact factor: 3.996

4.  Novel Phosphoinositides in Barley Aleurone Cells (Additional Evidence for the Presence of Phosphatidyl-scyllo-Inositol).

Authors:  B. Narasimhan; G. Pliska-Matyshak; R. Kinnard; S. Carstensen; M. A. Ritter; L. Von Weymarn; PPN. Murthy
Journal:  Plant Physiol       Date:  1997-04       Impact factor: 8.340

5.  High cerebral scyllo-inositol: a new marker of brain metabolism disturbances induced by chronic alcoholism.

Authors:  A Viola; F Nicoli; B Denis; S Confort-Gouny; Y Le Fur; J-P Ranjeva; P Viout; P J Cozzone
Journal:  MAGMA       Date:  2004-08-31       Impact factor: 2.310

6.  Properties of scyllo-inositol as a therapeutic treatment of AD-like pathology.

Authors:  Daniela Fenili; Mary Brown; Rebecca Rappaport; JoAnne McLaurin
Journal:  J Mol Med (Berl)       Date:  2007-02-06       Impact factor: 5.606

7.  A cell factory of Bacillus subtilis engineered for the simple bioconversion of myo-inositol to scyllo-inositol, a potential therapeutic agent for Alzheimer's disease.

Authors:  Masaru Yamaoka; Shin Osawa; Tetsuro Morinaga; Shinji Takenaka; Ken-ichi Yoshida
Journal:  Microb Cell Fact       Date:  2011-09-07       Impact factor: 5.328
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.